erwin mahajan's most recent trade in Brooks Laboratories Ltd. was a Acquisition of 70,970 Equity Shares done at an average price of Rs. 10 . Disclosure was reported to the exchange on Aug. 31, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
erwin mahajan's has made SAST transactions in Brooks Laboratories Ltd. recently where a Acquisition of 513,120 shares done . Disclosure was reported to the exchange on Feb. 17, 2021.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brooks Laboratories | Erwin Mahajan | Promoter Group | Acquisition | 31 Aug 2023 | 70,970 | 1,206,490 (4.60%) | 0.27% | 10 | 709,700 | 30 Aug 2023 30 Aug 2023 |
Insider Trading | Equity Shares | Public Right |
| Brooks Laboratories | Erwin Mahajan (Revised) | Promoter Group | Acquisition | 31 Aug 2023 | 70,970 | 1,206,490 (4.60%) | 0.27% | 75 | 5,322,750 | 30 Aug 2023 30 Aug 2023 |
Insider Trading | Equity Shares | Public Right |
| Brooks Laboratories | Erwin Mahajan | Directors Immediate Relative | Acquisition | 18 Feb 2021 | 513,120 | 1,135,520 (4.60%) | 2.08% | 0 | 0 | 16 Feb 2021 16 Feb 2021 |
Insider Trading | Equity Shares | Gift |
| Brooks Laboratories | Erwin Mahajan | Promoter | Acquisition | 17 Feb 2021 | 513,120 | 1,135,520 (4.60%) | 2.08% | - | 16 Feb 2021 16 Feb 2021 |
SAST (29(2)) | - | Inter-se Transfer |